TonshoffB., SchaeferF., MehlsO.Disturbance of growth hormone-insulin-like growth factor axis in uraemia: implications for recombinant human growth hormone treatment.Pediatr Nephrol1990; 4: 654–62.
2.
BaumannG.Growth hormone binding protein and free growth hormone in chronic renal failurePediatr Nephrol1996; 10: 328–30.
3.
LeeP.D.K., HintzR.L., SperryJ.B., BaxterR.C., PowellD.R.IgF binding proteins in growth retarded children with chronic renal failure.Pediatr Res1989; 27: 308–14.
4.
PowellD.R., LiuF., BakerB.K., LeeP.D.K., HintzR.L.Insulin-like growth factor binding proteins as growth inhibitors in children with chronic renal failure.Pediatr Nephrol1996; 10: 343–7.
5.
KochV.H., LippeB.M., NelsonP.A., Innes BoechatM., ShermanB.M., FineR.N.Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failure.J Pediatr1989; 115: 365–71.
6.
ItoK., KawaguchiH.Treatment of uremic children in Japan with recombinant human growth hormone (rhGH).Pediatr Endocrinol1994; 7: 115–18.
7.
ReesL., RigdonS.P.A., WardG., PreeceM.Treatment of short stature in renal disease with recombinant human growth hormone.Arch Dis Child1990; 65: 856–60.
8.
Hokken-KoelegaA.C.S., StijnenT., De Muinck KeizerSchramaSMPFPlacebo controlled double blind crossover trial of growth hormone treatment in prepubertal children with chronic renal failure.Lancet1991; 338: 585–90.
9.
FineR.N., KohautE.C., BrownD., PerlmanA.J.Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicentre randomized double blind placebo controlled study.J Pediatr1994; 124: 374–82.
10.
WuhlE., HaffnerD., NisselR., SchaeferF., MehlsO.Short dialyzed children respond less to growth hormone than patients prior to dialysis.Pediatr Nephrol1996; 10: 294–8.
11.
SchaeferF., WuhlE., HaffnerD., MehlsO.Stimulation of growth by recombinant human growth hormone in children undergoing peritoneal or hemodialysis treatment. In: KhannaR. ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications Inc., 1994; 10: 321–6.
12.
KaleA.S., LiuF., HintzR.L.Characterization of insulin-like growth factors and their binding proteins in peritoneal dialysate.Pediatr Nephrol1996; 10: 467–73.
13.
ValentiniR.P., MudgeN.A., BunchmanT.E.Dialysis modality comparison of insulin-like growth factor binding protein-3 removal in children: could this have a potential growth benefit? In: KhannaR. ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications Inc., 1994; 10: 327–30.
14.
WatkinsS.L.Is severe renal osteodystrophy acontraindication for recombinant human growth hormone treatment?Pediatr Nephrol1996; 10(3): 351–4.
15.
SaluskyI.B., GoodmanW.G.Growth hormone and calcitriol as modifiers of bone formation in renal osteodystrophy.Kidney Int1995; 48: 657–65.
